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Abstract
Background: Disturbances in lipid metabolism have been linked to suicidal behaviour, but little is known about
the association between suicide risk and abnormal glucose metabolism in depression. Hyperglycaemia and
hyperinsulinaemia may increase the risk of depression and also the risk for suicide, we therefore studied
associations between suicidal behaviour and disturbances in glucose metabolism in depressive patients who had
been referred to depression nurse case managers.
Methods: Patients aged 35 years and older (N = 448, mean age 51 years) who were experiencing a new depressive
episode, who were referred to depression nurse case managers in 2008–2009 and who scored ≥10 on the Beck
Depression Inventory were enrolled in this study. The study was conducted in municipalities within the Central Finland
Hospital District (catchment area of 274 000 inhabitants) as part of the Finnish Depression and Metabolic Syndrome in
Adults study. The patients’ psychiatric diagnoses and suicidal behaviour were confirmed by the Mini-International
Neuropsychiatric Interview. Blood samples, for glucose and lipid determinations, were drawn from participants after
12 h of fasting, which was followed by a 2-hour oral glucose tolerance test (OGTT) when blood was drawn at 0 and
2 h. Insulin resistance was measured by the Quantitative Insulin Sensitivity Check Index (QUICKI) method.
Results: Suicidal ideation (49 %) and previous suicide attempts (16 %) were common in patients with major
depressive disorder or dysthymia. Patients with depression and suicidal behaviour had higher blood glucose
concentrations at baseline and at 2 hours in the OGTT. Glucose levels associated positively with the prevalence of
suicidal behaviour, and the linearity was significant at baseline (p for linearity: 0.012, adjusted for age and sex) and for
2-hour OGTT glucose (p for linearity: 0.004, adjusted for age and sex). QUICKI levels associated with suicidal behavior
(p for linearity across tertiles of QUICKI: 0.026). Total and LDL cholesterol and triglyceride levels were also higher in
those patients with suicidal behaviour. Multivariate analysis revealed that blood glucose levels, BDI scores and
antidepressive medications associated with suicidal behaviour.
Conclusion: Insulin resistance and disturbances in glucose and lipid metabolism may be more common in middle-
aged depressive patients with suicidal behaviour.
Keywords: Cholesterol, Depression, Glucose, Insulin resistance, Suicidal behaviour, Ideation, Suicidality, Suicide attempt,
Triglyceride
* Correspondence: hannu.j.koponen@hus.fi
1Old Age Psychiatry, University of Helsinki, and Helsinki University Hospital,
P.O. Box 22FIN-00014 Helsinki, Finland
Full list of author information is available at the end of the article
© 2015 Koponen et al. This is an Open Access article distributed under the terms of the Creative Commons Attribution
License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any
medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://
creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Koponen et al. BMC Psychiatry  (2015) 15:163 
DOI 10.1186/s12888-015-0567-x
Background
Depression is thought to have multifaceted pathophysi-
ology and increased risk for having depression is related
to type two diabetes and other cardiometabolic disorders
[1–3]. Numerous studies have also documented an asso-
ciation between suicide risk and depression [4, 5]. In-
creased suicide risk in depression may be related to
various psychosocial factors, interpersonal conflicts and
negative life events [6]. However, recent studies have re-
ported an association between diabetes, depressive disor-
ders and suicidal ideation [7, 8], in addition to an
association between higher high glycated haemoglobin
(HbA1c) values and suicidal ideation in subjects with
diabetes [9]. Another cardiometabolic risk factor, distur-
bances in lipid metabolism, may also associate with im-
pulsiveness and suicidal behaviour [10].
The monoamine hypothesis states that depression is re-
lated to monoaminergic dysfunction [11]. Reduced sero-
tonin levels associate with increased weight, increased
waist circumference, elevated blood glucose levels and in-
sulin resistance in addition to depressed mood [12]. The
inflammatory hypothesis of depression emphasizes the
role of pro-inflammatory cytokines and cell-mediated im-
mune activation that results in tryptophan depletion and
serotonergic hypofunction [13–16]. Type 2 diabetes is rec-
ognized as an immune-mediated disease in which cyto-
kines play an important role that leads to impaired insulin
signaling and to the selective destruction of the insulin-
producing beta cells [17]. A possible underlying patho-
physiological mechanism for the emergence of abnormal
glucose metabolism in depression and suicidal behaviour
could thus lie in the interplay between serotonin and pro-
inflammatory cytokines [18–20].
Studies on the associations between depression, suicidal
behaviour, glucose levels or insulin resistance are scarce, al-
though some previous studies suggest that higher glucose
levels are associated with dysthymia [7] and higher HbA1c
concentrations with recurrent or psychotic depression [7].
Bot and co-workers reported an association between sui-
cidal ideation and HbA1c levels in diabetic subjects [9]. A
recent meta-analysis reported an association between de-
pression and insulin resistance [21]. The role of insulin se-
cretion is more obscure, though a longitudinal study found
that low insulin secretion is a risk factor for depression in
middle-aged women [22]. Hyperglycaemia and insulin re-
sistance may increase the risk of depression and also the
risk of suicide, thus, we decided to study the associations
between suicidal behaviour and disturbances in glucose
metabolism in depressive patients that had been referred
to depression nurse case managers.
Methods
Patients who were 35 years of age or older, who were
having a new depressive episode, who were referred to
depression nurse case managers in 2008–2009 and who
also scored ≥10 on the Beck Depression Inventory (BDI)
[23] were enrolled in this study. The study (Finnish De-
pression and Metabolic Syndrome in Adults (FDMSA)
study) was conducted in both urban and rural munici-
palities that were part of the Central Finland Hospital
District, Finland with a geographically unified catchment
area of 274 000 inhabitants. Enrolment was based on
written and oral patient information. Each enrolled pa-
tient gave her/his written consent. The Ethics Commit-
tee of Central Finland Hospital District had approved
the study protocol prior to the commencement of the
study. Depression and type two diabetes are more preva-
lent in the Finnish population after 35 years of age,
therefore we decided to focus on the ≥35 year-old age
group. The age limit of 35 years was also chosen to ob-
tain a stable study population, which facilitates having a
more prolonged follow-up. We obtained a representative
sample comprising both mild and more severely depres-
sive participants, by including self-referred patients
along with general practitioner referred patients. In
Finland, the depression nurse case managers are an im-
portant part of the basic health care team and they pri-
marily organize the treatment of depressed patients
together with the general practitioners. The patients
were treated according to the current Finnish treatment
guidelines for depression, i.e., with antidepressive medi-
cations and/or psychotherapy. If suicidal behaviour was
a serious current problem, then those suicidal patients
were further referred to a psychiatric hospital.
All participants completed a standard questionnaire
that contained questions about their use of medications,
which inter alia included antidepressant use and also
hormone replacement therapy in females. In addition,
data were collected on smoking habits, alcohol con-
sumption (number of drinks per week) and physical ac-
tivity (number of over-30-min exercise sessions per
week). The severity of depressive symptoms was ascer-
tained by scoring the responses to the 21-item BDI [23],
which all patients had to complete and the psychiatric
diagnosis was subsequently confirmed upon having a
diagnostic interview. The diagnostic interview was the
Mini-International Neuropsychiatric Interview (M.I.N.I.)
[24]. The M.I.N.I. is a structured diagnostic interview
that is compatible with the International Statistical Clas-
sification of Diseases and Related Health Problems,
Tenth Revision (ICD-10), and the Diagnostic and Statis-
tical Manual of Mental Disorders, Fourth Edition (DSM-
IV). Suicidal behaviour was defined in the present study
according to the M.I.N.I. suicidal behaviour module as
‘suicidal ideation during the past month’ or ‘suicide at-
tempt during the past month or in a lifetime’. A total of
706 referred patients scored 10 or more for the BDI.
However, only 448 patients were selected for the study
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population after having the diagnostic interview after
which they were deemed to have met the criteria for
major depressive disorder or for dysthymia.
Fasting blood samples were drawn between 8 and 11
o’clock after 12 h of fasting for glucose and lipid level
determinations. This was followed by a 2-hour oral glu-
cose tolerance test at 0 and 2 h sampling (OGTT). The
physical examination included the participants’ weight,
height, waist circumference and blood pressure measure-
ments, which were taken during the same study visit.
Height and weight of the participants were determined
with the participants wearing light clothing and was ac-
curate to the nearest 0.5 cm and 0.1 kg, respectively.
The waist circumference was measured to the nearest
1.0 cm at the midpoint between the lateral iliac crest
and the lowest rib. Trained nurses measured blood pres-
sure twice with a mercury sphygmomanometer while pa-
tients/participant who had first been rested for 15 min
were in a sitting position.
Modular Analytics SWA (Hitachi High-Technologies
Corporation, Tokyo, Japan) served to determine serum
total cholesterol, HDL cholesterol, LDL cholesterol, tri-
glycerides and plasma glucose. The concentrations of
serum insulin were analysed by a Siemens Advia Cen-
taur (Siemens Health Care Diagnostics, Dublin, Ireland).
We applied all the routine quality control procedures of
an accredited clinical laboratory (Central Finland Hos-
pital District, Clinical laboratory) including regular test-
ing of standard samples. The sensitivity of the insulin
assay was 2.4 U/l, and the intra- and inter-assay coeffi-
cients of variation were 5.3 % and 7.6 %, respectively. In-
sulin resistance may co-occur with depression, therefore
we also calculated the Quantitative Insulin Sensitivity
Check Index (QUICKI) on the basis of the insulin and
glucose levels according to the equation: QUICKI = 1/
[log(I0) + log (G0)], in which I0 is fasting insulin, and
G0 is fasting glucose [25]. In QUICKI, low values are as-
sociated with insulin resistance.
Statistical analysis
The results are presented as means, interquartile ranges,
standard deviations and frequency distributions. We
used the Student’s t-test, Mann–Whitney-U-test and the
chi-square test to test for statistical significance between
groups. The multivariate logistic regression model was
used to investigate factors related to suicidal behaviour,
and clinically relevant variables without covariability
were selected from Table 1 for the procedure. We then
used generalized linear models with the appropriate dis-
tribution and link functions to evaluate the statistical
significance for the hypotheses of linearity. Any viola-
tions of the assumptions (non-normality), were evalu-
ated by a bootstrap-type test. The normality of the
variables was tested by using the Shapiro-Wilk W test.
Results
Nearly half 218 (49 %) of the 448 participants had sui-
cidal thoughts, whereas 72 (16 %) of participants also
had previously attempted suicide according to the results
of the M.I.N.I. interview. Participants with depression
and suicidal behaviour had higher blood glucose levels at
baseline and at 2 hours with the OGTT (Table 1).
The blood glucose concentrations associated positively
with the prevalence of suicidal behaviour (Fig. 1), and
linearity was significant for baseline glucose concentra-
tions (p for linearity: 0.012, adjusted for age and sex)
and for 2-hour OGTT glucose concentrations (p for lin-
earity: 0.004, adjusted for age and sex adjusted). The OR
for suicidal behaviour for the highest vs. the lowest ter-
tile of fasting glucose concentrations at baseline for the
OGTT was 2.18 (95 % CI: 1.27–3.74) whereas the corre-
sponding tertile values for 2-hour glucose, OR was 1.99
(95 % CI: 1.64–3.38). The baseline or 2-hour insulin
levels were not significantly different from each other,
but QUICKI levels showed a significant association with
suicidal behaviour (p for linearity across tertiles of
QUICKI: 0.026; Fig. 2). When the 72 patients who had a
previous suicide attempt were scrutinized separately
from the 218 patients who had suicidal ideation, no sta-
tistically significant linearity in the OGTT values was
observed.
Of the other cardiometabolic risk factors, total and
LDL cholesterol and triglyceride levels were higher
among participants who had either suicidal ideation or
who had previously attempted suicide (Table 1). Patients
with suicidal behaviopur also smoked more frequently,
and alcohol dependence was also more common
(Table 1). In the multivariate analysis, plasma glucose
levels, BDI score and antidepressive medication associ-
ated with suicidal behaviour. No associations with sui-
cidal behaviour and age, prevalence of type 2 diabetes,
gender distribution, smoking, alcohol use disorder, or
chronic diseases were found (Table 2).
Discussion
A novel finding in our study was the observed associ-
ation between higher plasma glucose/blood glucose
levels, insulin resistance and suicidal behaviour in de-
pression. Nearly half of the participants in our study re-
ported suicidal ideation or previous attempts at suicide,
which were as frequent as those reported in another re-
cent Finnish study, the Vantaa Depression Study [26].
Cases with a history of suicidal behaviour also had
higher triglyceride concentrations in addition to elevated
total and LDL cholesterol levels. Statins may slightly in-
crease the risk for developing diabetes [27], but as the
use of statins in our study was more prevalent in the
subgroup with no suicidal behaviour our finding cannot
be therefore attributed to statin medication. The
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multivariate analysis revealed that plasma glucose levels,
BDI scores and antidepressive medications positively as-
sociated with suicidal behaviour. No associations with
suicidal behaviour and age, prevalence of type 2 diabetes,
gender distribution, smoking, alcohol use disorder, or
chronic diseases were found however. With the excep-
tion of hypertension, cardiovascular diseases (CVDs)
were rare due to the comparatively low age of the study
population. Although a recent study found an associ-
ation between obesity and suicidal behaviour [28], our
Table 1 Groups taking part in the FDMSA study
No suicidal ideation and behaviour N = 230 Suicidal ideation and attempts in M.I.N.I. N = 218 p
Women, n (%) 169 (74) 143 (66) 0.059
Age, mean (SD) 51 (10) 51 (10) 0.64
Age 65+ years old, n (%) 22 (10) 22 (10) 0.66
Education years, mean (SD) 11.2 (2.9) 11.2 (2.8) 0.95
Working status, n (%) 0.15
Employed 108 (47) 81 (37)
Retired 61 (27) 62 (28)
Unemployed 56 (24) 69 (32)
Student 4 (2) 6 (3)
Household income, 1000€, median (IQR) 24 (12, 40) 20 (10, 35) 0.50
BMI, mean (SD) 27.9 (5.8) 28.2 (5.9) 0.49
Blood pressure (mmHg), mean (SD)
Systole 130 (16) 131 (15) 0.45
Diastole 82 (11) 82 (11) 0.90
Plasma Glucose, mmol/l, mean (SD)
0 h 5.71 (1.17) 6.07 (1.68) 0.013
2 h 5.85 (1.83) 6.69 (3.01) 0.0013
Insu0, U/l, mean (SD) 9.65 (8.08) 10.97 (8.38) 0.11
Insu1, U/l, mean (SD) 58.5 (58.9) 69.3 (69.9) 0.12
QUICKI, mean (SD) 0.16 (0.01) 0.15 (0.01) 0.023
Total cholesterol (mmol/l), mean (SD) 4.97 (0,98) 5.22 (1.06) 0.017
HDL cholesterol (mmol/l), mean (SD) 1.61 (0.50) 1.53 (0.45) 0.089
LDL cholesterol (mmol/l), mean (SD) 2.90 (0.83) 3.21 (1.00) <0.001
Triglyceride (mmol/l), mean (SD) 1.29 (0.77) 1.48 (0.92) 0.025
BDI score, mean (SD) 21 (7) 26 (8) <0.001
median (IQR) 20 (15, 25) 26 (20, 32)
Smoking, n (%) 56 (24) 86 (39) <0.001
Coronary heart disease, n (%) 12 (5) 9 (4) 0.58
Arterial hypertension, n (%) 69 (30) 64 (29) 0.86
Previous stroke, n (%) 7 (3) 0 (0) 0.015
T2D, n (%) 30 (13) 24 (11) 0.50
Alcohol use disorder, n (%) 21 (9) 39 (18) 0.007
Antidepressive medication, n (%) 139 (61) 170 (78) <0.001
Statin medication, n (%) 57 (25) 39 (18) 0.007
Leisure time physical activity, n (%) 0.824
Low 79 (35) 71 (33)
Moderate 56 (25) 50 (24)
High 91 (40) 92 (43)
T2D type 2 diabetes, BMI body mass index, QUICKI quantitative insulin sensitivity check index, Insu0 baseline serum insulin level, Insu1 serum insulin level after 2-hour
OGTT, BDI beck depression inventory, IQR interquartile range
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study population showed no differences in body mass
index levels.
We observed higher blood glucose for the OGTT both
at baseline and at 2-hour sampling in patients with sui-
cidal ideation or who had previously attempted suicide.
Ceretta et al. [7] reported three-fold higher suicidal idea-
tion rates in insulin-treated type 2 diabetic patients,
which suggested an association between suicidal tenden-
cies and blood glucose levels. Type 2 diabetes was more
common in the subgroup with no suicidal behaviour in
our study and this suggests that the observed association
cannot solely be due to type 2 diabetes. Bot and co-
workers [9] also reported an association between higher
HbA1c values and depressive mood, sleep disturbance,
appetite problems and suicidal ideation. Their study
population comprised participants with either type 1 or
type 2 diabetes, and the associations were more pro-
found in type 1 diabetes [9]. Han and co-workers have
also reported an increased risk for suicidal ideation in
adults with diabetes and depression [8], but none of the
previous studies have specifically studied the association
between glucose levels and suicidal tendencies behaviour
in depressed patients.
The association observed between glucose levels and
suicidal behaviour may be related to the cytokine-
mediated inflammatory process that results in the activa-
tion of indoleamine 2,3-dioxygenase, the depletion of
tryptophan and suicidal behaviour related to emerging
serotonergic hypofunction, depression and impulsivity
[13, 17, 29, 30]. The groups in the present study showed
no differences in baseline and 2-hour insulin levels,
which suggests insulin resistance rather than insufficient
insulin secretion was the probable associated factor. In
addition, the surrogate index for insulin resistance,
QUICKI, showed a significant association with suicidal
behaviour, which lends further support for the associ-
ation between disturbed glucose metabolism and suicidal
behaviour. However, the patients with suicidal behaviour
in our study also had higher BDI scores, so the severity
of depression and the higher prevalence of alcohol use
disorder in this group of patients may also have contrib-
uted to suicidal behaviour [31, 32]. In addition, hyperac-
tivation of the hypothalamic-pituitary-adrenal axis has
been reported in 20 to 80 % of depressed individuals
[33]. This hyperactivity has been put forward as an im-
portant mechanism that explains both the pathophysi-
ology of depression and also its relationship with
medical conditions such as diabetes and obesity. Higher
cortisol levels are associated with age and more severe
forms of depression, such as melancholic and psychotic
depression, and may thus also contribute to the associ-
ation between higher BDI levels and risk of suicidal be-
havior [33, 34].
Previous studies have identified smoking as a possible
risk factor for attempted and also completed suicide
[35]. Smoking has been linked to serotonergic dysfunc-
tion [3]. Serum cholesterol has been suggested to reflect
the serotonergic function of the central nervous system
and to participate in cognitive functioning in addition to
mood regulation [10]. Low cholesterol levels have been
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Fig. 1 Age and sex-adjusted association between baseline and 2-hour OGTT glucose tertiles and suicidal behaviour
Koponen et al. BMC Psychiatry  (2015) 15:163 Page 5 of 8
linked by some studies to impulsiveness and the risk of
suicide in depressive patients [10, 36, 37]. However, an-
other study has reported that high cholesterol [38] con-
centrations to be associated with suicidal behaviour. In
this study, we found higher total and higher LDL choles-
terol levels in participants with suicidal behaviour, which
is in line with the results of Silic et al. [18], who also re-
ported an association between low platelet serotonin,
and high interleukin IL-6, and glucose. The higher trigly-
ceride levels were probably related to the insulin resist-
ance or unhealthy lifestyles that were more common in
the subgroup with suicidal behaviour [29].
The strengths of our study include its extensive and
geographically representative sample of middle-aged and
elderly subjects. We also used a diagnostic interview to
complement the self-rating of the depressive symptoms.
However, we cannot draw inferences about the causality
due to the cross-sectional design of our study, which is a
limitation. In addition, only persons aged 35 or older
were enrolled in the study, so the results cannot be gen-
eralized to younger age groups. The evaluation of insulin
resistance by QUICKI relying on the mathematical mod-
elling of fasting plasma glucose and insulin concentra-
tion may also be a limitation, although a recent study
reported that QUICKI results were comparable to a
euglycemic hyperinsulinemic clamp and superior to
measurements based on insulin alone [39].
Conclusions
The observed association between plasma glucose levels,
insulin resistance and suicidal behaviour suggests that
disturbances in glucose metabolism are associated with
suicidal ideation and attempts. However, further studies
are necessary to elucidate the pathophysiology behind
these associations, and it remains obscure whether the
treatment of cardiometabolic risk factors lowers the risk
of suicidal behaviour.
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Fig. 2 Age and sex-adjusted association between QUICKI tertiles and
suicidal behavior
Table 2 Associations between suicidal behaviour and patient
characteristics
OR (95 % CI) P-value
Men 1.58 (0.91 to 2.76) 0.10
Age 0.99 (0.95 to 1.02) 0.36
Education years 1.03 (0.95 to 1.12) 0.44
Working status
Employed 1 (Reference)
Retired 2.07 (1.04 to 4.11) 0.038
Un-employed 1.22 (0.69 to 2.16) 0.49
Student 1.34 (0.25 to 7.14) 0.74
BMI 1.02 (0.97 to 1.06) 0.49
Plasma Glucose* tertiles
I (≤5.2) 1 (Reference) 0.008 (linearity)
II (5.3 to 5.8) 1.33 (0.74 to 2.41)
III (≥5.9) 2.50 (1.26 to 4.94)
BDI score 1.10 (1.06 to 1.13) <0.001
Smoking 1.66 (0.99 to 2.76) 0.051
Coronary heart disease 1.32 (0.43 to 4.10) 0.63
Arterial hypertension 0.84 (0.45 to 1.55) 0.57
T2D 0.69 (0.31 to 1.57) 0.38
Alcohol use disorder 0.81 (0.39 to 1.68) 0.57
Antidepressive medication 2.15 (1.30 to 3.54) 0.003
Statin medication 0.55 (0.29 to 1.05) 0.071
Leisure time physical activity
Low 1 (Reference) 0.45 (linearity)
Moderate 0.77 (0.43 to 1.39)
High 0.81 (0.48 to 1.37)
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